Good morning,
We have news today from one of newest 'collaborators'.
RenovoRx today announced the expansion of their clinical development pipeline in preparation for the commencement of a second Phase III trial. The CouGar Trial will evaluate RenovoGem in bile duct cancer, specifically unresectablelocally advanced extrahepatic cholangio carcinoma (eCCA).
Makes me wonder how things might progress when Vaxinia was added to this process? If we continue to see positive signs in our trial, and the RenovoGem trial is positive, and gains FDA approval, we may have a 'super-charged' treatment for this horrific condition.
The tipping point is coming ...
Opinion only.
Good morning,We have news today from one of newest...
-
- There are more pages in this discussion • 6,060 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
-0.002(2.78%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.4¢ | 5.4¢ | 5.2¢ | $129.2K | 2.449M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 39 | 3350382 | 5.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.3¢ | 601549 | 17 |
View Market Depth
| Last trade - 15.15pm 22/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |